139 related articles for article (PubMed ID: 12651860)
1. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway.
Ghiselli G; Coffee N; Munnery CE; Koratkar R; Siracusa LD
J Biol Chem; 2003 May; 278(22):20259-67. PubMed ID: 12651860
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
3. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138
[TBL] [Abstract][Full Text] [Related]
5. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.
Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA
J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
Hossain A; Saunders GF
J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.
Lévy L; Wei Y; Labalette C; Wu Y; Renard CA; Buendia MA; Neuveut C
Mol Cell Biol; 2004 Apr; 24(8):3404-14. PubMed ID: 15060161
[TBL] [Abstract][Full Text] [Related]
8. The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway.
Ghiselli G; Agrawal A
Biochem J; 2005 Sep; 390(Pt 2):493-9. PubMed ID: 15853773
[TBL] [Abstract][Full Text] [Related]
9. Global gene expression profiling of cells overexpressing SMC3.
Ghiselli G; Liu CG
Mol Cancer; 2005 Sep; 4():34. PubMed ID: 16156898
[TBL] [Abstract][Full Text] [Related]
10. [Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells].
Zhu HX; Zhang G; Wang YH; Zhou CQ; Bai JF; Xu NZ
Ai Zheng; 2004 Jul; 23(7):737-41. PubMed ID: 15248904
[TBL] [Abstract][Full Text] [Related]
11. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4.
Hecht A; Stemmler MP
J Biol Chem; 2003 Feb; 278(6):3776-85. PubMed ID: 12446687
[TBL] [Abstract][Full Text] [Related]
12. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
13. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
14. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
15. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H
Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
17. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.
Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
Front Immunol; 2021; 12():688493. PubMed ID: 34621263
[TBL] [Abstract][Full Text] [Related]
18. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
19. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
[TBL] [Abstract][Full Text] [Related]
20. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]